Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 85Osteosarcoma 30Neuroectodermal Tumors, Primitive, Peripheral 16Fibrosarcoma 16Rhabdomyosarcoma 14Liposarcoma 14Hemangiosarcoma 13Neurofibrosarcoma 12Leiomyosarcoma 12Histiocytoma, Malignant Fibrous 12Sarcoma, Synovial 11Malignant mesenchymal tumor 9Sarcoma, Ewing 8Ovarian Neoplasms 8Hemangiopericytoma, Malignant 8Kidney Neoplasms 6Dendritic Cell Sarcoma, Interdigitating 6Wilms Tumor 5Sarcoma, Alveolar Soft Part 5Neoplasms 5Desmoplastic Small Round Cell Tumor 5Chondrosarcoma 5Carcinoma, Renal Cell 5Neuroblastoma 4Neoplasm Metastasis 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Dermatofibrosarcoma 4Chondrosarcoma, Extraskeletal Myxoid 4Central Nervous System Neoplasms 4

Interventions

dexamethasone acetate 2Vincristine 2Mesna 2Ifosfamide 2Doxorubicin 2Dexamethasone 2Calcium Dobesilate 2fosaprepitant 1Palonosetron 1Ondansetron 1Octreotide 1Electroacupuncture 1Dexrazoxane 1Cyproheptadine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nausea × Ifosfamide × Sarcoma × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡